City of Hope Receives $36 Million for State-of-the-Art Hospital

Publication
Article
OncologyONCOLOGY Vol 13 No 8
Volume 13
Issue 8

The City of Hope National Medical Center and Beckman Research Institute received the largest individual gift in the cancer center’s 86-year history from Irwin Helford, chairman of Viking Office Products and vice chairman of Office Depot. The

The City of Hope National Medical Center and Beckman Research Institute received the largest individual gift in the cancer center’s 86-year history from Irwin Helford, chairman of Viking Office Products and vice chairman of Office Depot. The Los Angeles business icon and philanthropist has donated $36 million to kick off construction of a state-of-the-art, 144-bed facility to accommodate the needs of cancer patients into the next century.

“City of Hope is extremely honored and grateful to be the recipient of this generous gift. This not only represents the most significant contribution in our history, but also and more importantly, serves as a critical contribution toward the future of cancer care,” said Gil N. Schwartzberg, chairman and chief executive officer of City of Hope.

Innovative Design

The new hospital, slated for construction next year, is being developed with an innovative universal patient-room concept, designed to accommodate virtually any patient-care setting, including intensive care, bone marrow transplantation, medical/surgical, and outpatient. The facility will support clinical research and will meet all recently developed state hospital earthquake requirements. The hospital will be dedicated as the Betty and Irwin Helford Clinical Research Hospital at its anticipated opening in 2004, according to City of Hope officials.

Mr. Helford’s association with City of Hope began in 1983 and was highlighted in 1994, when he was honored by the Office Products Council, an industry support organization for City of Hope. Mr. Helford received “The Spirit of Life” Award for creating a unique worldwide catalog business, raising the level of service for customers in the United States, Europe, and Australia, and for his long-time support of City of Hope. He served on the Executive Council for two terms. Since its inception in 1983, the Office Products Council has raised more than $14 million for research and treatment at the national cancer center. Mr. Helford’s prior personal gifts of more than $2 million were recognized in 1997 with the renaming of one of the existing research buildings.

Recent Videos
Elucidating nonresponses to bispecific T-cell engagers may be an important research consideration in the multiple myeloma field.
Barriers to access and financial toxicities are challenges that must be addressed for CAR T-cell therapies in LBCL, according to Jose Sandoval Sus, MD.
Fixed treatment durations with bispecific antibodies followed by observation may help in mitigating infection-related AEs, according to Shebli Atrash, MD.
2 experts are featured in this series.
Epistemic closure, broad-scale distribution, and insurance companies are the 3 largest obstacles to implementing new peritoneal surface malignancy care guidelines into practice.
2 experts are featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Shebli Atrash, MD, stated that MRD should be considered carefully as an end point, given potential recurrence despite MRD negativity.
Related Content